Nick Hart
Directeur/Membre du Conseil chez ProSpect Pharma, Inc.
Profil
Nick Hart is currently a Director at ProSpect Pharma, Inc. He was previously the President at Hemcon Medical Technologies, Inc. from 2011 to 2012 and the Chief Financial Officer at Neuro3D SA.
Postes actifs de Nick Hart
Sociétés | Poste | Début |
---|---|---|
ProSpect Pharma, Inc.
ProSpect Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services ProSpect Pharma, Inc. provides drug designing services. It develops and markets and uses advanced technologies and products for the Life Science industries, particularly those related to drug design, vaccine development and metabolic studies. The company was founded in 2004 and is headquartered in Baltimore, MD. | Directeur/Membre du Conseil | 31/05/2010 |
Anciens postes connus de Nick Hart
Sociétés | Poste | Fin |
---|---|---|
Hemcon Medical Technologies, Inc.
Hemcon Medical Technologies, Inc. Medical DistributorsDistribution Services Hemcon Medical Technologies, Inc. develops, manufactures, and markets technologies to control bleeding and infection resulting from trauma or surgery. Its solutions include military, emergency and trauma, dental, hemodialysis center, sports medicine, EMS, Cardiac Cath, IR and electrophysiology, wound debridement, occupational healthcare, and wilderness medicine solutions. The company was founded by William Wiesmann, Kenton Gregory, and Simon McCarthy in 2001 and is headquartered in Portland, OR. | Directeur Financier/CFO | - |
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Hemcon Medical Technologies, Inc.
Hemcon Medical Technologies, Inc. Medical DistributorsDistribution Services Hemcon Medical Technologies, Inc. develops, manufactures, and markets technologies to control bleeding and infection resulting from trauma or surgery. Its solutions include military, emergency and trauma, dental, hemodialysis center, sports medicine, EMS, Cardiac Cath, IR and electrophysiology, wound debridement, occupational healthcare, and wilderness medicine solutions. The company was founded by William Wiesmann, Kenton Gregory, and Simon McCarthy in 2001 and is headquartered in Portland, OR. | Distribution Services |
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Health Technology |
ProSpect Pharma, Inc.
ProSpect Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services ProSpect Pharma, Inc. provides drug designing services. It develops and markets and uses advanced technologies and products for the Life Science industries, particularly those related to drug design, vaccine development and metabolic studies. The company was founded in 2004 and is headquartered in Baltimore, MD. | Commercial Services |